Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Water-Soluble Vitamin And Mineral Feed Supplements Industry?

The market for drugs targeting neurological disorders has seen a robust expansion in recent years. It is set to escalate from $84.6 billion in 2024 to $89.24 billion in 2025, marking a compound annual growth rate (CAGR) of 5.5%. The surge in this historical phase is due to factors such as increased animal testing yielding optimistic results, a rise in therapeutic interventions, an upsurge in neurological issues, governmental strategies, and expanded healthcare outlay.

The market for drugs treating neurological disorders is expected to witness a robust expansion in the coming years. It’s projected to increase to “$110.99 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The promising growth during the forecast period can be attributed to the evolution of therapeutic alternatives, personalization of therapies, an increasing emphasis on disease-modifying treatment, wider application of digital biomarkers, and the rising occurrence of neurological ailments. Key trends projected during the forecast period comprise development in drug design, enhancement in neuroimaging, progress in genetic research, various collaboration and licensing deals, and the advent of regenerative medicine.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17207&type=smp

#Which Factors Are Currently Driving The Growth Of The Water-Soluble Vitamin And Mineral Feed Supplements Market?

The escalating population of livestock is projected to fuel the expansion of the water-soluble vitamin and mineral feed supplements market. Livestock are animals that are raised or kept for various reasons, such as usage, pleasure, or profit, with a particular focus on farm-raised species. These animals, which include cattle, hogs, horses, poultry, sheep, and small animals, are bred and sustained by agricultural producers. These livestock can be given water-soluble vitamin and mineral nutritional supplements for purposes such as healthy bone development and maintaining reproductive efficiency. For example, as reported by Eurostat in March 2023, the statistical office based in Luxembourg indicated an increase of 330,000 pigs in Italy’s population from November to December 2022 – a 4% rise compared to 2021. Also, Sweden experienced a growth in their pig population by 50,000 heads, or a 3% increase from the prior year. In summary, the European Union held a considerable livestock population in May 2022, estimated at 142 million pigs, 76 million cattle, 60 million sheep, and 11 million goats. This rise in livestock population is henceforth triggering the growth of the water-soluble vitamin and mineral feed supplements market.

The neurological disorder drugs market covered in this report is segmented –

1) By Drug Class: Cholinesterase Inhibitors, N-Methyl-D-Aspartate (NMDA) Receptor Antagonists, Antiepileptic, Antipsychotic And Antidepressant, Other Drugs Classes

2) By Indication: Epilepsy, Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Cerebrovascular Disease, Other Indications

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:

1) By Cholinesterase Inhibitors: Donepezil, Rivastigmine, Galantamine

2) By N-Methyl-D-Aspartate (NMDA) Receptor Antagonists: Memantine, Other NMDA Receptor Antagonists

3) By Antiepileptic: Sodium Channel Blockers, GABA Enhancers, Glutamate Modulators, Other Antiepileptics

4) By Antipsychotic and Antidepressant: Risperidone, Olanzapine, SSRIs, SNRIs, Tricyclic

5) By Other Drug Classes: Dopaminergic Drugs, Alpha-2 Agonists, Immunomodulators, Other Neurological Disorder Medications

What Long-Term Trends Are Likely To Affect The Water-Soluble Vitamin And Mineral Feed Supplements Market?

Leading enterprises in the neurological disorder drugs sector are heavily investing in the innovation of Ocrelizumab drug therapies. Their aim is to improve the effectiveness of treatments, boost patient results, and offer more choice for individuals afflicted with multiple sclerosis. Ocrelizumab, a humanized monoclonal antibody, is utilized as a medicinal drug in treating multiple sclerosis (MS), a form of neurological disorder. As an illustration, Roche Holding AG, a pharmaceutical firm based in Switzerland, introduced Ocrevus, an Ocrelizumab-based disease-modifying therapy (DMT) drug for the treatment of multiple sclerosis in India in February 2024. Ocrevus stands as the premiere and only approved DMT for both relapsing-remitting multiple sclerosis (RRMS) and primary progressive multiple sclerosis (PPMS), driven by a decade’s worth of clinical and real-world data. This monoclonal antibody takes aim at CD20-positive B cells, known for their role in the autoimmune assault on the central nervous system in multiple sclerosis (MS) cases. Ocrevus has been approved for the treatment of both RRMS and PPMS, setting a precedent as the first drug approved for both forms of the disease. This drug is delivered intravenously, usually biannually, and has proven effective in curtailing disease activity and slowing down disability progression in clinical trials.

Who Are The Main Participants Shaping The Water-Soluble Vitamin And Mineral Feed Supplements Market Landscape?

Major companies operating in the neurological disorder drugs market are F. Hoffmann-La Roche Ltd, Bayer AG, Sanofi S.A, AstraZeneca PLC, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company Pvt Ltd, Amgen Inc, Boehringer Ingelheim GmbH, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd, Otsuka America Pharmaceutical Inc, Biogen Inc, Bausch Health Companies Inc, Alexion Pharmaceuticals Inc., UCB S.A., Eisai Co Ltd, Cipla Inc, BioMarin Pharmaceutical Inc., Biocon Ltd, Acorda Therapeutics Inc.

https://www.thebusinessresearchcompany.com/report/neurological-disorder-drugs-global-market-report

Which Region Currently Holds The Largest Share In The Water-Soluble Vitamin And Mineral Feed Supplements Market?

North America was the largest region in the neurological disorder drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurological disorder drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=17207&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model